Functionality of NGF-protected PC12 cells following exposure to 6-hydroxydopamine

Biochemical and Biophysical Research Communications

Volumn 351, Issue 4, 2006, Pages 890-895

  Kavanagh, Edel T ^a   Loughlin, John P ^a   Herbert, Kate Reed ^a   Dockery, Peter ^a   Samali, Afshin ^a   Doyle, Karen M ^a   Gorman, Adrienne M ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Apoptosis; Catecholamines; Dopamine; Necrosis; Neurite outgrowth; Parkinson's disease; Tyrosine hydroxylase

Indexed keywords

BETA TUBULIN; CASPASE; CATECHOLAMINE; CELL PROTEIN; LACTATE DEHYDROGENASE; NERVE GROWTH FACTOR; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL PROTECTION; CELL STRAIN; CONTROLLED STUDY; DRUG EXPOSURE; ENZYME ACTIVITY; ENZYME RELEASE; FUNCTIONAL ASSESSMENT; INTRACELLULAR MEMBRANE; NECROSIS; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CATECHOLAMINES; CELL DIFFERENTIATION; CELL PROLIFERATION; NECROSIS; NERVE GROWTH FACTOR; NEURITES; NEURONS; OXIDOPAMINE; PC12 CELLS; RATS; TUBULIN; TYROSINE 3-MONOOXYGENASE;

EID: 33750813040     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.10.104     Document Type: Article

References (20)

1. Huang E.J., and Reichardt L.F. Trk receptors: roles in neuronal signal transduction. Annu. Rev. Biochem. 72 (2003) 609-642
2. Deshmukh M., and Johnson Jr. E.M. Programmed cell death in neurons: focus on the pathway of nerve growth factor deprivation-induced death of sympathetic neurons. Mol. Pharmacol. 51 (1997) 897-906
3. Takadera T., and Ohyashiki T. Apoptotic cell death and CPP32-like activation induced by thapsigargin and their prevention by nerve growth factor in PC12 cells. Biochim. Biophys. Acta 1401 (1998) 63-71
4. Andsberg G., Kokaia Z., Bjorklund A., Lindvall O., and Martinez-Serrano A. Amelioration of ischaemia-induced neuronal death in the rat striatum by NGF-secreting neural stem cells. Eur. J. Neurosci. 10 (1998) 2026-2036
5. Levivier M., Przedborski S., Bencsics C., and Kang U.J. Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease. J. Neurosci. 15 (1995) 7810-7820
6. Shimoke K., Amano H., Kishi S., Uchida H., Kudo M., and Ikeuchi T. Nerve growth factor attenuates endoplasmic reticulum stress-mediated apoptosis via suppression of caspase-12 activity. J. Biochem. (Tokyo) 135 (2004) 439-446
7. Yao R., and Cooper G.M. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267 (1995) 2003-2006
8. Samali A., Zhivotovsky B., Jones D., Nagata S., and Orrenius S. Apoptosis: cell death defined by caspase activation. Cell Death Differ. 6 (1999) 495-496
9. Thoenen H., and Tranzer J.P. Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-hydroxydopamine. Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol. 261 (1968) 271-288
10. Blum D., Torch S., Lambeng N., Nissou M., Benabid A.L., Sadoul R., and Verna J.M. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog. Neurobiol. 65 (2001) 135-172
11. Gorman A.M., Szegezdi E., Quigney D.J., and Samali A. Hsp27 inhibits 6-hydroxydopamine-induced cytochrome c release and apoptosis in PC12 cells. Biochem. Biophys. Res. Commun. 327 (2005) 801-810
12. Salinas M., Diaz R., Abraham N.G., Ruiz de Galarreta C.M., and Cuadrado A. Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner. J. Biol. Chem. 278 (2003) 13898-13904
13. Greene L.A., and Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA 73 (1976) 2424-2428
14. O'Keeffe G.W., Dockery P., and Sullivan A.M. Effects of growth/differentiation factor 5 on the survival and morphology of embryonic rat midbrain dopaminergic neurones in vitro. J. Neurocytol. 33 (2004) 479-488
15. Harkin A., Connor T.J., Mulrooney J., Kelly J.P., and Leonard B.E. Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats. Life Sci. 68 (2001) 1367-1382
16. Pong Ng Y., He W., and Ip N.Y. Leukemia inhibitory factor receptor signaling negatively modulates nerve growth factor-induced neurite outgrowth in PC12 cells and sympathetic neurons. J. Biol. Chem. 278 (2003) 38731-38739
17. Nagatsu T., Levitt M., and Udenfriend S. Tyrosine hydroxylase. The initial step in norepinephrine biosynthesis. J. Biol. Chem. 239 (1964) 2910-2917
18. Chaturvedi R.K., Shukla S., Seth K., and Agrawal A.K. Nerve growth factor increases survival of dopaminergic graft, rescue nigral dopaminergic neurons and restores functional deficits in rat model of Parkinson's disease. Neurosci. Lett. 398 (2006) 44-49
19. Lim R.R., Bloomfield M.R., Johnson A.M., and Allen J.M. Dopamine concentrations in PC12 cells following neuronal differentiation induced by NGF or VIP. Biochem. Soc. Trans. 23 (1995) 46S
20. Bartholini G., Pletscher A., and Richards J. 6-Hydroxydopamine-induced inhibition of brain catecholamine synthesis without ultrastructural damage. Experientia 26 (1970) 598-600